Focal Nature of Neurological Disorders Necessitates Isotype-Selective Histone Deacetylase (HDAC) Inhibitors (original) (raw)

• Saha RN, Pahan K (2006) HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 13:539–550
  PubMed CAS Google Scholar
• Hahnen E, Hauke J, Trankle C, Eyupoglu IY, Wirth B, Blumcke I (2008) Histone deacetylase inhibitors: possible implications for neurodegenerative disorders. Expert Opin Investig Drugs 17:169–184
  PubMed CAS Google Scholar
• Abel T, Zukin RS (2008) Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 8:57–64
  PubMed CAS Google Scholar
• Morrison BE, Majdzadeh N, D'Mello SR (2007) Histone deacetylases: focus on the nervous system. Cell Mol Life Sci 64:2258–2269
  PubMed CAS Google Scholar
• Marsh JL, Lukacsovich T, Thompson LM (2009) Animal models of polyglutamine diseases and therapeutic approaches. J Biol Chem 284:7431–7435
  PubMed CAS Google Scholar
• Kazantsev AG, Thompson LM (2008) Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 7:854–868
  PubMed CAS Google Scholar
• Graybiel AM (1995) The basal ganglia. Trends Neurosci 18:60–62
  PubMed CAS Google Scholar
• Graybiel AM (2005) The basal ganglia: learning new tricks and loving it. Curr Opin Neurobiol 15:638–644
  PubMed CAS Google Scholar
• Knowlton BJ, Mangels JA, Squire LR (1996) A neostriatal habit learning system in humans. Science 273:1399–1402
  PubMed CAS Google Scholar
• Carelli RM (2002) The nucleus accumbens and reward: neurophysiological investigations in behaving animals. Behav Cogn Neurosci Rev 1:281–296
  PubMed Google Scholar
• Milner B, Squire LR, Kandel ER (1998) Cognitive neuroscience and the study of memory. Neuron 20:445–468
  PubMed CAS Google Scholar
• Squire LR (2004) Memory systems of the brain: a brief history and current perspective. Neurobiol Learn Mem 82:171–177
  PubMed Google Scholar
• Morris RG, Garrud P, Rawlins JN, O'Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297:681–683
  PubMed CAS Google Scholar
• Zoghbi HY, Orr HT (2000) Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23:217–247
  PubMed CAS Google Scholar
• HsDCR G (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72:971–983
  Google Scholar
• Andrew SE et al (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 4:398–403
  PubMed CAS Google Scholar
• Li JL et al (2006) Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23–24: the HD MAPS study. BMC Med Genet 7:71
  PubMed Google Scholar
• Rosenblatt A, Abbott MH, Gourley LM, Troncoso JC, Margolis RL, Brandt J, Ross CA (2003) Predictors of neuropathological severity in 100 patients with Huntington's disease. Ann Neurol 54:488–493
  PubMed Google Scholar
• Bamford KA, Caine ED, Kido DK, Plassche WM, Shoulson I (1989) Clinical–pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study. Neurology 39:796–801
  PubMed CAS Google Scholar
• Hedreen JC, Peyser CE, Folstein SE, Ross CA (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 133:257–261
  PubMed CAS Google Scholar
• Rosas HD et al (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60:1615–1620
  PubMed CAS Google Scholar
• Fennema-Notestine C et al (2004) In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 63:989–995
  PubMed CAS Google Scholar
• Jeste DV, Barban L, Parisi J (1984) Reduced Purkinje cell density in Huntington's disease. Exp Neurol 85:78–86
  PubMed CAS Google Scholar
• Rodda RA (1981) Cerebellar atrophy in Huntington's disease. J Neurol Sci 50:147–157
  PubMed CAS Google Scholar
• Byers RK, Dodge JA (1967) Huntington's chorea in children. Report of four cases. Neurology 17:587–596
  PubMed CAS Google Scholar
• La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77–79
  PubMed Google Scholar
• Nagafuchi S, Yanagisawa H, Ohsaki E, Shirayama T, Tadokoro K, Inoue T, Yamada M (1994) Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA). Nat Genet 8:177–182
  PubMed CAS Google Scholar
• Koide R et al (1994) Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 6:9–13
  PubMed CAS Google Scholar
• Yazawa I, Nukina N, Hashida H, Goto J, Yamada M, Kanazawa I (1995) Abnormal gene product identified in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) brain. Nat Genet 19:99–103
  Google Scholar
• Ross CA, Becher MW, Colomer V, Engelender S, Wood JD, Sharp AH (1997) Huntington's disease and dentatorubral-pallidoluysian atrophy: proteins, pathogenesis and pathology. Brain Pathol 7:1003–1016
  PubMed CAS Google Scholar
• Takahashi H, Ohama E, Naito H, Takeda S, Nakashima S, Makifuchi T, Ikuta F (1988) Hereditary dentatorubral-pallidoluysian atrophy: clinical and pathologic variants in a family. Neurology 38:1065–1070
  PubMed CAS Google Scholar
• Riley BE, Orr HT (2006) Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle. Genes Dev 20:2183–2192
  PubMed CAS Google Scholar
• Duenas AM, Goold R, Giunti P (2006) Molecular pathogenesis of spinocerebellar ataxias. Brain 129:1357–1370
  PubMed Google Scholar
• Campuzano V et al (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423–1427
  PubMed CAS Google Scholar
• Butler R, Bates GP (2006) Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nat Rev Neurosci 7:784–796
  PubMed CAS Google Scholar
• Helmlinger D, Tora L, Devys D (2006) Transcriptional alterations and chromatin remodeling in polyglutamine diseases. Trends Genet 22:562–570
  PubMed CAS Google Scholar
• Steffan JS et al (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413:739–743
  PubMed CAS Google Scholar
• Ferrante RJ et al (2004) Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease. J Neurosci 24:10335–10342
  PubMed CAS Google Scholar
• Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, Smith KM, Ferrante RJ (2006) ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc Natl Acad Sci U S A 103:19176–19181
  PubMed CAS Google Scholar
• Stack EC et al (2007) Modulation of nucleosome dynamics in Huntington's disease. Hum Mol Genet 16:1164–1175
  PubMed CAS Google Scholar
• Freiman RN, Tjian R (2002) Neurodegeneration. A glutamine-rich trail leads to transcription factors. Science 296:2149–2150
  PubMed Google Scholar
• Zhai W, Jeong H, Cui L, Krainc D, Tjian R (2005) In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets. Cell 123:1241–1253
  PubMed CAS Google Scholar
• Benn CL, Sun T, Sadri-Vakili G, McFarland KN, DiRocco DP, Yohrling GJ, Clark TW, Bouzou B, Cha JH (2008) Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. J Neurosci 28:10720–10733
  PubMed CAS Google Scholar
• Cooper JR, Bloom FE, Roth RH (1991) Dopamine. In: Cooper JR, Bloom FE, Roth RH (eds) The biochemical basis of neuropharmacology. Oxford University Press, Oxford, pp 285–337
  Google Scholar
• Stephens B et al (2005) Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 132:741–754
  PubMed CAS Google Scholar
• Tamminga CA (2006) The neurobiology of cognition in schizophrenia. J Clin Psychiatry 67:e11
  Article PubMed Google Scholar
• Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177–184
  PubMed CAS Google Scholar
• Feltenstein MW, See RE (2008) The neurocircuitry of addiction: an overview. Br J Pharmacol 154:261–274
  PubMed CAS Google Scholar
• Simunovic F, et al. (2008) Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology_._ Brain. doi:10.1093/brain/awn323
• Mirnics K, Levitt P, Lewis DA (2006) Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry 60:163–176
  PubMed CAS Google Scholar
• Thomas EA (2006) Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders. Mol Neurobiol 34:109–128
  PubMed CAS Google Scholar
• Yuferov V, Nielsen D, Butelman E, Kreek MJ (2005) Microarray studies of psychostimulant-induced changes in gene expression. Addict Biol 10:101–118
  PubMed CAS Google Scholar
• Nicholas AP et al (2008) Striatal histone modifications in models of levodopa-induced dyskinesia. J Neurochem 106:486–494
  PubMed CAS Google Scholar
• Kumar A et al (2005) Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48:303–314
  PubMed CAS Google Scholar
• Levine AA, Guan Z, Barco A, Xu S, Kandel ER, Schwartz JH (2005) CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum. Proc Natl Acad Sci U S A 102:19186–19191
  PubMed CAS Google Scholar
• Bruijn LI, Miller TM, Cleveland DW (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27:723–749
  PubMed CAS Google Scholar
• Pasinelli P, Brown RH (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7:710–723
  PubMed CAS Google Scholar
• Jonsson PA, Graffmo KS, Andersen PM, Brannstrom T, Lindberg M, Oliveberg M, Marklund SL (2006) Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain 129:451–464
  PubMed Google Scholar
• Monani UR (2005) Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron 48:885–896
  PubMed CAS Google Scholar
• Schmidt-Kastner R, Freund TF (1991) Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 40:599–636
  PubMed CAS Google Scholar
• Papadopoulos MC, Giffard RG, Bell BA (2000) An introduction to the changes in gene expression that occur after cerebral ischaemia. Br J Neurosurg 14:305–312
  PubMed CAS Google Scholar
• Read SJ et al (2001) Stroke genomics: approaches to identify, validate, and understand ischemic stroke gene expression. J Cereb Blood Flow Metab 21:755–778
  PubMed CAS Google Scholar
• Quina AS, Buschbeck M, Di Croce L (2006) Chromatin structure and epigenetics. Biochem Pharmacol 72:1563–1569
  PubMed CAS Google Scholar
• Kornberg RD, Lorch Y (1999) Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98:285–294
  PubMed CAS Google Scholar
• Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403:41–45
  PubMed CAS Google Scholar
• Sterner DE, Berger SL (2000) Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64:435–459
  PubMed CAS Google Scholar
• An W (2007) Histone acetylation and methylation: combinatorial players for transcriptional regulation. Subcell Biochem 41:351–369
  PubMed Google Scholar
• Xu WS, Parmigiani RB, Marks PA (2007) Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26:5541–5552
  PubMed CAS Google Scholar
• Blander G, Guarente L (2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73:417–435
  PubMed CAS Google Scholar
• Gao L, Cueto MA, Asselbergs F, Atadja P (2002) Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 277:25748–25755
  PubMed CAS Google Scholar
• Roth SY, Denu JM, Allis CD (2001) Histone acetyltransferases. Annu Rev Biochem 70:81–120
  PubMed CAS Google Scholar
• Hildmann C, Riester D, Schwienhorst A (2007) Histone deacetylases—an important class of cellular regulators with a variety of functions. Appl Microbiol Biotechnol 75:487–497
  PubMed CAS Google Scholar
• Adcock IM, Ford P, Ito K, Barnes PJ (2006) Epigenetics and airways disease. Respir Res 7:21
  PubMed Google Scholar
• Lucio-Eterovic AK et al (2008) Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas. BMC Cancer 8:243
  PubMed Google Scholar
• Zhou X, Marks PA, Rifkind RA, Richon VM (2001) Cloning and characterization of a histone deacetylase, HDAC9. Proc Natl Acad Sci U S A 98:10572–10577
  PubMed CAS Google Scholar
• Liu H, Hu Q, Kaufman A, D'Ercole AJ, Ye P (2008) Developmental expression of histone deacetylase 11 in the murine brain. J Neurosci Res 86:537–543
  PubMed CAS Google Scholar
• Broide RS, Redwine JM, Aftahi N, Young W, Bloom FE, Winrow CJ (2007) Distribution of histone deacetylases 1–11 in the rat brain. J Mol Neurosci 31:47–58
  PubMed CAS Google Scholar
• Southwood CM, Peppi M, Dryden S, Tainsky MA, Gow A (2007) Microtubule deacetylases, SirT2 and HDAC6, in the nervous system. Neurochem Res 32:187–195
  PubMed CAS Google Scholar
• Hoshino M et al (2003) Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein. J Neurochem 87:257–267
  PubMed CAS Google Scholar
• Pandey UB et al (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447:859–863
  PubMed CAS Google Scholar
• Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao TP (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115:727–738
  PubMed CAS Google Scholar
• Iwata A, Riley BE, Johnston JA, Kopito RR (2005) HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem 280:40282–40292
  PubMed CAS Google Scholar
• Pallos J, Bodai L, Lukacsovich T, Purcell JM, Steffan JS, Thompson LM, Marsh JL (2008) Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease. Hum Mol Genet 17:3767–3775
  PubMed CAS Google Scholar
• Bates EA, Victor M, Jones AK, Shi Y, Hart AC (2006) Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. J Neurosci 26:2830–2838
  PubMed CAS Google Scholar
• Bolden JE, Peart MJ, Johnstone RW (2006) Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5:769–784
  PubMed CAS Google Scholar
• Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC (2005) Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol 45:495–528
  PubMed CAS Google Scholar
• Khan N et al (2008) Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 409:581–589
  PubMed CAS Google Scholar
• Bieliauskas AV, Pflum MK (2008) Isoform-selective histone deacetylase inhibitors. Chem Soc Rev 37:1402–1413
  PubMed CAS Google Scholar
• Chou CJ, Herman DM, Gottesfeld JM (2008) Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I histone deacetylases. J Biol Chem 283:35402–35409
  PubMed CAS Google Scholar
• Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, Gottesfeld JM (2006) Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol 2:551–558
  PubMed CAS Google Scholar
• Thomas EA et al (2008) The HDAC inhibitor, 4b, ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice. Proc Natl Acad Sci U S A 105:15564–15569
  PubMed CAS Google Scholar
• Beckers T, Burkhardt C, Wieland H, Gimmnich P, Ciossek T, Maier T, Sanders K (2007) Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group. Int J Cancer 121:1138–1148
  PubMed CAS Google Scholar
• Hockly E et al (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A 100:2041–2046
  PubMed CAS Google Scholar
• Ferrante RJ et al (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 23:9418–9427
  PubMed CAS Google Scholar
• Gardian G et al (2005) Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem 280:556–563
  PubMed CAS Google Scholar
• Hahnen E et al (2006) In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. J Neurochem 98:193–202
  PubMed CAS Google Scholar
• Avila AM et al (2007) Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J Clin Invest 117:659–671
  PubMed CAS Google Scholar
• Minamiyama M et al (2004) Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet 13:1183–1192
  PubMed CAS Google Scholar
• Ying M, Xu R, Wu X, Zhu H, Zhuang Y, Han M, Xu T (2006) Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA. J Biol Chem 281:12580–12586
  PubMed CAS Google Scholar
• Rai M, Soragni E, Jenssen K, Burnett R, Herman D, Coppola G, Geschwind DH, Gottesfeld JM, Pandolfo M (2008) Correction of frataxin deficiency in a GAA repeat knock-in mouse model for Friedreich ataxia by a specific histone deacetylase inhibitor. PLoS ONE 3:e1958
  PubMed Google Scholar
• Petri S, Kiaei M, Kipiani K, Chen J, Calingasan NY, Crow JP, Beal MF (2006) Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 22:40–49
  PubMed CAS Google Scholar
• Ryu H et al (2005) Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J Neurochem 93:1087–1098
  PubMed CAS Google Scholar
• Gardian G, Yang L, Cleren C, Calingasan NY, Klivenyi P, Beal MF (2004) Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity. Neuromolecular Med 5:235–241
  PubMed CAS Google Scholar
• Pandey SC, Ugale R, Zhang H, Tang L, Prakash A (2008) Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci 28:3729–3737
  PubMed CAS Google Scholar
• Romieu P, Host L, Gobaille S, Sandner G, Aunis D, Zwiller J (2008) Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. J Neurosci 28:9342–9348
  PubMed CAS Google Scholar
• Fontan-Lozano A, Romero-Granados R, Troncoso J, Munera A, Delgado-Garcia JM, Carrion AM (2008) Histone deacetylase inhibitors improve learning consolidation in young and in KA-induced-neurodegeneration and SAMP-8-mutant mice. Mol Cell Neurosci 39:193–201
  PubMed CAS Google Scholar
• Thomas P, Vieta E (2008) Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial. Neuropsychiatr Dis Treat 4:675–686
  PubMed CAS Google Scholar
• Buckley PF (2008) Update on the treatment and management of schizophrenia and bipolar disorder. CNS Spectr 13:1–10 quiz 11–12
  PubMed Google Scholar
• Tremolizzo L et al (2005) Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry 57:500–509
  PubMed CAS Google Scholar
• Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM (2007) Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 321:892–901
  PubMed CAS Google Scholar
• Faraco G, Pancani T, Formentini L, Mascagni P, Fossati G, Leoni F, Moroni F, Chiarugi A (2006) Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol 70:1876–1884
  PubMed CAS Google Scholar
• Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM (2004) Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 89:1358–1367
  PubMed CAS Google Scholar
• Zhang B, West EJ, Van KC, Gurkoff GG, Zhou J, Zhang XM, Kozikowski AP, Lyeth BG (2008) HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats. Brain Res 1226:181–191
  PubMed CAS Google Scholar
• Simonini MV, Camargo LM, Dong E, Maloku E, Veldic M, Costa E, Guidotti A (2006) The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci U S A 103:1587–1592
  PubMed CAS Google Scholar
• Van Lint C, Emiliani S, Verdin E (1996) The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Exp 5:245–253
  Google Scholar
• Peart MJ, Smyth GK, van Laar RK, Bowtell DD, Richon VM, Marks PA, Holloway AJ, Johnstone RW (2005) Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc Natl Acad Sci U S A 102:3697–3702
  PubMed CAS Google Scholar
• Chiba T, Yokosuka O, Arai M, Tada M, Fukai K, Imazeki F, Kato M, Seki N, Saisho H (2004) Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. J Hepatol 41:436–445
  PubMed CAS Google Scholar
• Schroeder TM, Nair AK, Staggs R, Lamblin AF, Westendorf JJ (2007) Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors. BMC Genomics 8:362
  PubMed Google Scholar